Archive
Home / Media Centre / Archive
Here you can find the archive of all Press Releases prior to 2023
Filter by date:
Showing 1262 press releases before 2023
-
AstraZeneca advances the science of cancer medicine with practice-changing data at the ASCO20 Virtual Scientific Program
-
XTRA AstraZeneca advances the science of cancer medicine with practice-changing data at the ASCO20 Virtual Scientific Program
-
Enhertu granted Breakthrough Therapy Designation in the US for HER2-positive metastatic gastric cancer
-
AstraZeneca recovery of global rights to brazikumab (MEDI2070) from Allergan completed
-
Lynparza approved in the US as 1st-line maintenance treatment with bevacizumab for HRD-positive advanced ovarian cancer
-
Lynparza approved in the US as 1st-line maintenance treatment with bevacizumab for HRD-positive advanced ovarian cancer EXTRA
-
Farxiga approved in the US for the treatment of heart failure in patients with heart failure with reduced ejection fraction
-
AstraZeneca and Oxford University announce landmark agreement for COVID-19 vaccine
-
First-quarter 2020 results
-
Lynparza demonstrated overall survival benefit in Phase III PROfound trial for BRCA1/2 or ATM-mutated metastatic castration-resistant prostate cancer
Latest articles and press releases
All of our latest press releases and articles are available to explore
Use a maximum of two downloads here
